Background and purpose: There is widespread geographic variation in healthcare quality, but we often lack clear strategies for improving quality in underserved areas. This study characterized geographic disparities in stroke care quality to assess whether improved access to neurological services has the potential to bridge the care quality gap, particularly in terms of alteplase (rt-PA) administration. Methods: This was a retrospective study using quality performance data from the 2015 Hospital Compare database linked to information on certification status from the Joint Commission and information on local access to neurological services from the Area Health Resources File. We used these data to compare stroke care quality according to geographic area, certification, and neurologist access. Results: Non-metropolitan hospitals performed worse than metropolitan hospitals on all assessed stroke care quality measures. The most prevalent disparity occurred in the use of rt-PA for eligible patients (52.2% versus 82.7%, respectively). Certified stroke centers in every geographic designation provided higher quality of care, whereas large variation was observed among non-certified hospitals. Regression analyses suggested that improvements in hospital certification or access to neurologists were associated with absolute improvements of 44.9% and 21.3%, respectively, in the percentage of patients receiving rt-PA. Conclusions: The large quality gap in stroke care between metropolitan and non-metropolitan areas could be at least partly addressed through improved procedural efforts by stroke center certification increasing the supply of neurological services, (i.e. through training and hiring new neurologists) or by adopting decision support systems such as telemedicine.
Introduction
While decades of research have demonstrated regional variation in the quality of healthcare in the United States, it is especially pronounced in stroke care [1] . Rural and underserved areas are associated with a higher prevalence of stroke, as well as worse care and patient outcomes [2, 3] . In these areas it is challenging to provide prompt stroke treatment and clinical expertise that can prevent stroke-related disability and mortality [4] .
A number of factors contribute to these geographic disparities. Prompt treatment with clot-dissolving thrombolytic drugs, such as alteplase (rt-PA), within 3 h of an acute ischemic stroke (AIS) can restore blood flow in the brain before substantial damage occurs [5, 6] . While rt-PA administration is the standard of care for patients with AIS and is recommended by organizations such as the American Heart Association and American Stroke Association [7] [8] [9] , fewer than 5% of patients who suffer from an AIS in the US receive rt-PA [10] . Even fewer patients living in regions with limited stroke-systems of care are administered rt-PA, which may be due to long distances these patients must travel to stroke centers [11] [12] [13] .
Further, clinical expertise is essential to rapid diagnosis and treatment. Receiving care at a specialized stroke center, such as a Joint Commission (JC)-certified Primary Stroke Center (PSC), is associated with improved outcomes, as emergency physicians (EPs) often lack experience with rt-PA and are reluctant to use it [12] . Only 1% of individuals in rural areas, however, live within a 60-minute ground ambulance ride of a PSC [14] .
Given the need for prompt evaluation and treatment, often including a neurological consult, there is concern that rt-PA is especially underused in rural or underserved urban areas. More generally, improving access to neurological services likely can improve the quality of care and outcomes for many patients with stroke, but it is unknown to what extent regional disparities in stroke care are related to disparities in access to neurological services [15] . In light of this, the objective of our study was to document the quality gaps that exist in stroke care, particularly as measured by rt-PA administration, between metropolitan and nonmetropolitan areas and quantify the extent to which these gaps are associated with disparities in access to neurological services. We also explored the impact of potential approaches to bridge these gaps.
Methods
Data based on 2013-2014 discharges were obtained from the fiscal year (FY) 2015 Hospital Compare, a database operated by the Centers for Medicare & Medicaid Services that provides information on hospital performance by measuring the percentage of patients within each hospital who meet a set of quality criteria [16, 17] . The data are collected through the Hospital Inpatient Quality Reporting (Hospital IQR) program [18] .
CMS began collecting data on eight stroke quality measures (STK-1 through STK-6, STK-8 and STK-10) in calendar year 2013 (the relevant data year for FY 2015) [19] . Hospitals reporting performance data on at least one stroke measure were assumed to provide stroke care to patients on at least a semi-regular basis and were included.
We used information from the US Department of Agriculture RuralUrban Continuum Codes to classify hospitals (within the 50 states only) into different categories based on the size of metropolitan area or proximity to urban areas [20] . Specifically, we categorized hospitals as largemetropolitan, medium-metropolitan, small-metropolitan, or non-metropolitan based on continuum codes of 1, 2, 3 and 4-9, respectively. Geographic information was assigned to hospitals using Federal Information Processing Standard (FIPS) codes. Institutions were further characterized by their JC stroke center certification status, which is offered at multiple levels. Requirements for PSC and Comprehensive Stroke Center (CSC) status are described in Table I in the Online-only Supplement. The list of certified hospitals was obtained from the JC website [21] . Finally, to measure the level of access to neurological services in a given geographic area, we used the per-capita number of neurologists from the 2013 Area Health Resources Files (AHRF) [22] . Patients living in areas with a larger number of specialists per capita are more likely to receive specialist care, making the number of neurologists per capita a proxy variable for access to neurological stroke services [23] . One limitation to this measure is that many neurologists practice in an outpatient setting or do not provide acute stroke care regularly [24] . To test the sensitivity of our results, we also used the per-capita number of neurosurgeons to measure the level of access to acute neurological services. Physician data by specialty are based on counts from the American Medical Association Masterfile, while the population counts by county are based on 2013 estimates from the US Census Bureau.
To document the gap in care quality among hospitals according to geographic designation and JC certification, average performance levels on stroke measures were calculated. Mean differences in performance were tested for significance by paired t-tests.
The association between access to neurological services and quality of care was assessed using multivariable regression analysis, in which hospitals were stratified by access to neurological services and JC certification status after controlling for location, and for an indicator of volume as a sensitivity analysis. Additionally, to understand systematic differences in reporting that may bias our results, the qualitative level of stroke care was estimated as the probability of hospitals reporting stroke quality measures, controlling for location, access to neurological services, and certification level. In these analyses, counties were identified as having high access to neurologists if they were in the top 25% of all counties based on their per-capita number of neurologists, or low access for those in the bottom 25%.
To measure the clinical significance of different policies addressing gaps in care quality, we simulated the impact on patient outcomes under three hypothetical scenarios according to their association with rt-PA administration: an uncertified non-metropolitan hospital becoming certified; a low-access non-metropolitan hospital becoming high access (based on the number of neurologists per capita); and a non-metropolitan hospital adopting telemedicine. Changes in rt-PA administration rates informing the simulations above were estimated from the Hospital Compare data for the first two scenarios and from observational studies for the third scenario (Online-only Supplement Table II ) [25] [26] [27] [28] . The clinical relationship between rt-PA use and patient outcomes was obtained from a recent meta-analysis [29] .
Results
Performance measures reported between April 1, 2013 and March 13, 2014 were examined for 4765 US institutions in the FY 2015 Hospital Compare dataset. A total of 2758 (57.9%) reported at least one stroke measure and were included in our analysis. Large metropolitan hospitals were about twice as likely to report a performance indicator for stroke as non-metropolitan hospitals (75.4% and 36.3%, respectively; Table 1 ), with a more pronounced difference in STK-4 reporting (32.6% vs. 2.3% among all hospitals, and 41.7% vs. 6.3% among hospitals reporting any STK measure; Online-only Supplement Table III) .
Of the eight STK measures assessed, the reported performance of hospitals was lowest for STK-4, which measures administration of rt-PA in eligible patients ( Table 2 ). On average, only 77.9% of eligible patients received rt-PA across all hospitals, whereas the reported performance for all other stroke quality measures was over 87%.
When examining hospitals by geographic area, performance on all eight stroke indicators was higher in metropolitan hospitals than nonmetropolitan hospitals (Table 2 ; differences were statistically significant at 5%). The greatest disparity observed was for the administration of rt-PA. At large, medium and small metropolitan area hospitals, the average rt-PA administration rates were 82.7%, 77.2%, and 68.4%, respectively, and these rates were 30.5% (82.7% vs. 52.2%), 25.0% (77.2% vs. 52.2%), and 16.2% (68.4% vs. 52.2%) higher than the average rt-PA administration rate in non-metropolitan areas (Fig. 1) . Aside from rt-PA use, quality gaps were also pronounced for access to stroke education (STK-8) and statin medication (STK-6), with between-group absolute differences of 9.1% and 9.6%, respectively.
Hospitals in different geographic areas were also analyzed by their level of stroke center certification (Fig. 1) . We found a positive association between quality of stroke care and JC certification status, as evidenced by greater rt-PA administration among eligible patients at JCcertified hospitals, regardless of geographic area.
Although reported quality was higher at JC-certified hospitals in all areas, some treatment gaps were evident between rural and urban settings. In particular, the gap in rt-PA administration between a certified and non-certified hospital was 13.2% (86.2% vs. 73.0%) at large metropolitan area hospitals, compared with 44.9% (83.2% vs. 38.3%) in nonmetropolitan areas.
The association between rt-PA administration and per-capita number of neurologists at the county level (i.e., low, moderate, and high access to neurological services) was also assessed for both certified and non-certified hospitals. We found the rate of neurologists per capita was associated with increased rt-PA administration, even after controlling for hospital location. The absolute difference in rt-PA use of 21.3% (70.4% vs. 49.1%) between low and high access non-certified hospitals equals approximately half of the gap between certified and non- certified hospitals in non-metropolitan areas (Fig. 2) . This gap remained after controlling for patient volume (Online-only Supplement Fig. I ). Furthermore, sensitivity analyses using alternative measures of access based on neurosurgeons per capita yielded very similar results (Online-only Supplement Fig. II and III) . Our analysis also revealed that areas with greater access to neurological services were more likely to report the STK-4 measure, (Fig. 2) . Certified hospitals with high access to neurological services reported STK-4 approximately 1.6 times (59.0% vs. 36.7%) more often than those in lowaccess areas. Among non-certified hospitals, those with high access were approximately 3.5 times (9.0% vs. 2.6%) more likely to report STK-4 than hospitals with low access to neurological care.
The three hypothetical scenarios we simulated were (i) an uncertified non-metropolitan hospital becoming certified; (ii) a low-access non-metropolitan hospital becoming high access; and (iii) a nonmetropolitan hospital adopting telemedicine. These scenarios represent a 44.9%, 21.3%, and 22% (using the conservative rate of improvement in rt-PA administration) absolute improvement in rt-PA administration, respectively. The simulated drop in the number of dead or dependent patients, as measured by a Modified Rankin Score (mRS 2-6), for the three scenarios were 23, 11, and 11 out of 1000 stroke patients, respectively (Table 3) .
Discussion
Our findings demonstrated a significant quality gap between metropolitan and non-metropolitan area hospitals at the national level, especially with the rate of rt-PA administration and provision of stroke education. The administration of rt-PA (STK-4) was reported for 52.2% of patients in non-metropolitan area hospitals, compared with 82.7% of patients in large metropolitan area hospitals. Since JC stroke center certification requires instituting care protocols, our results suggest that such certification may eliminate substantial care quality gaps based on geographic location [4, 30] .
Our analysis further showed that, for non-certified hospitals, the level of access to neurological services was positively associated with the quality of stroke care, which is most evident for rt-PA use. Indeed, the average quality gap for rt-PA use between low-and high-access non-certified hospitals was estimated to be 21.3% (Fig. 2) . A previous report analyzing Medicare fee-for-service patients using claims data have shown geographic disparities in thrombolysis treatment [13] . Our findings agree with their conclusion; however, we analyze a broader population and rely on data reported by hospital. Although it is generally 
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The association between hospitals reporting rt-PA use (assessed by STK-4 score) and per-capita number of neurologists showed a notable disparity in the probability of reporting STK-4 based on level of access, suggesting that hospitals in low-access areas are less likely to have the infrastructure to administer rt-PA. JC, Joint Commission; rt-PA, alteplase.
Table 3
Simulation of rural hospital parameter changes on patient outcomes. Number of patients with death or dependency as measured by a mRS 3-6
Number of patients who were dependent at the end of follow-up as indicated by a mRS 3-5
Number of patients who were treated within 3 h but died or were dependent; randomized within 0-3 and 3-6 hour windows
Number of patients who were treated between 3 and 6 h but died or were dependent; randomized within 0-3 and 3-6 hour windows
Number of patients who were alive and independent (mRS 0-2) at end of follow-up; treated within 3 h 41 19 20 Number of patients who were alive and independent (mRS 0-2) at end of follow-up; treated between 3 and 6 h recognized that increasing access to neurological services in underserved areas can improve stroke care quality [13] , it may be challenging and also cost-prohibitive to find skilled professionals. With growing demand for treatment of other neurological disorders, such as Alzheimer's disease, training and hiring additional neurologists may not substantially close the gap in quality stroke care. A possible solution to this issue of disparity in access to neurological services is to better leverage the time of stroke neurologists through telemedicine. Observational studies have demonstrated that introducing telemedicine has the potential to increase the rate of rt-PA use by an absolute difference of 2.2%-5.1% among patients with stroke (Online-only Supplement Table II ) [25] [26] [27] [28] . When combined with the observations of a recent study finding that approximately one in 10 patients were fully eligible for rt-PA treatment [31] , there is potential for an increase in STK-4 performance of 22%-51% with the implementation of telemedicine.
The simulated impact of incorporating telemedicine improved patient outcomes by an amount that was comparable to our hypothetical scenario in which a rural hospital changed from low to high access for neurological services. While this is not conclusive, it is consistent with the idea that implementing telemedicine could bridge the quality gap between low-and high-access hospitals. Since hiring a full-time stroke neurologist may be impractical for many non-metropolitan hospitals, telemedicine could be a reasonable alternative to improve access to specialist services and provide higher quality care to their patients with stroke [32] .
Telemedicine, however, is not the only solution to increasing access to neurological services for patients with stroke. Given the importance of distance-related obstacles to receiving rt-PA, mobile stroke units, ambulances equipped with CT scanners and on-board or remote neurological services have been utilized in other countries to reduce the time from stroke onset to treatment [30, 33] . In the United States, initiatives like education programs and toolkits for Emergency Medical Service providers have been effective in reducing distance-related barriers for stroke care, as they enable these emergency workers to better identify stroke symptoms and provide care [34] . Additionally, the "drip and ship" method, in which patients are administered rt-PA in a local emergency room and transferred to a stroke center, can increase the rate of rt-PA use [35] .
Our study has several limitations. First, the methodology used did not allow us to measure the causal impact of access to neurological services on stroke care quality. It is reasonable to assume that hospitals in low-access counties are different from hospitals in high-access counties in terms of characteristics beyond those measured in this study, which may affect the quality of care. Moreover, we cannot control for potential confounding differences in the patient population across hospitals, such as stroke severity, comorbidities, and measures of socioeconomic status. In addition, we were only able to measure disparities in quality of care for hospitals reporting STK measures and thus were unable to measure the potential impact of increased access to neurological services when hypothetically "turning" a hospital into a stroke-ready institution. Therefore, it is possible that the impact of access to neurological services on improving stroke care has been underestimated in this study.
The data generated from our analysis also have inherent limitations. We measured the level of access to neurological services as the percapita number of neurologists in each county. In reality, neurologists with adequate skills to evaluate stroke patients are a small subset of all neurologists, although the per-capita number of all neurologists is likely positively correlated to the per-capita number of stroke neurologists (the requirement for it to serve as a proxy variable). However, sensitivity analyses confirmed that our results are robust for alternative measures of access.
We also assumed that hospitals reporting STK measures provided stroke care on a semi-regular basis; however, because of insufficient data we did not stratify hospitals by their volume of patients with stroke. Since Hospital Compare did not collect data on the STK measures prior to 2013, reporting in our data was low overall and disproportionally so in non-metro areas -particularly in terms of STK-4. Thus the sample of reporting hospitals may not be representative of all hospitals in a given location.However, we found that reporting errors are reasonably stable across locations (Online-only Supplement Table  IV) . Moreover, differences in measured performance may reflect differences in hospital coding and documentation, which maybe correlated with level of certification.
Furthermore, when identifying stroke centers, we relied exclusively on JC certification. Other certifying authorities exist, and these were not captured by the analysis. While JC certification ensures the highest standards of care [21] , excluding other certifications may overestimate the impact of access to neurological services. Also, our dataset does not indicate how many non-certified hospitals in our sample currently use telemedicine, which could result in an overestimation of the impact of telemedicine in the simulation. Finally, it is unknown whether there currently is a sufficient supply of neurologists who would be willing to participate in the expansion of telemedicine beyond its current levels.
Conclusions
In our study, we found that the quality gap in stroke care between metropolitan and non-metropolitan areas is significant. These findings also suggest that adequate access to neurological services may improve rates of rt-PA use. However, given the current shortage of neurologists in the US [36] , telemedicine -which has been demonstrated to be an effective method in the treatment of stroke [25] [26] [27] [28] -could improve outcomes for rt-PA-eligible patients with stroke in under-resourced hospitals by facilitating access to neurological services.
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